Profile data is unavailable for this security.
About the company
SCHOTT Pharma AG & Co. KGaA is a Germany-based company. The Company is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
- Revenue in EUR (TTM)996.56m
- Net income in EUR150.74m
- Incorporated2022
- Employees4.81k
- LocationSCHOTT Pharma AG & Co KgaAHattenbergstrasse 10MAINZ 55122GermanyDEU
- Phone+49 6131660
- Fax+49 6 131662000
- Websitehttps://www.schott-pharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gerresheimer AG | 2.25bn | 23.35m | 687.00m | 13.54k | 29.42 | 0.4901 | 2.46 | 0.3053 | 0.676 | 0.676 | 65.15 | 40.59 | 0.5455 | 3.73 | 7.85 | 185,328.90 | 0.6341 | 3.30 | 0.8716 | 4.68 | 26.89 | 30.04 | 1.16 | 5.84 | 0.5214 | 2.08 | 0.6022 | 41.29 | 2.28 | 7.90 | -5.52 | 6.32 | 17.58 | -49.35 |
| Paul Hartmann AG | 2.43bn | 81.51m | 782.36m | 10.09k | 9.54 | 0.6635 | 4.06 | 0.3224 | 22.95 | 22.95 | 682.93 | 330.05 | 1.16 | 1.97 | 5.54 | 240,745.70 | 4.12 | 4.21 | 5.45 | 5.79 | 59.56 | 57.30 | 3.56 | 3.35 | 1.11 | 14.11 | 0.2465 | 37.95 | 2.32 | 1.95 | 281.58 | 13.23 | 10.08 | 2.71 |
| Eckert & Ziegler SE | 304.47m | 40.62m | 950.20m | 1.11k | 23.14 | 4.04 | 16.64 | 3.12 | 0.6465 | 0.6328 | 4.85 | 3.70 | 0.6527 | 3.48 | 6.10 | 280,619.30 | 8.85 | 8.62 | 11.06 | 10.43 | 47.25 | 48.53 | 13.55 | 14.18 | 2.37 | 68.35 | 0.166 | 32.12 | 20.22 | 10.63 | 33.40 | 12.70 | 18.84 | 3.30 |
| Draegerwerk AG & Co KGaA | 3.42bn | 120.88m | 1.49bn | 16.68k | 10.85 | 0.8689 | 5.55 | 0.4344 | 6.45 | 6.45 | 182.35 | 80.56 | 1.13 | 2.51 | 5.01 | 206,009.00 | 4.00 | 3.72 | 5.94 | 5.59 | 45.35 | 44.54 | 3.53 | 3.49 | 1.03 | 7.96 | 0.1637 | 16.12 | -0.0778 | 3.92 | 12.65 | 37.91 | 0.4683 | 59.64 |
| SCHOTT Pharma AG & Co KgaA | 996.56m | 150.74m | 2.26bn | 4.81k | 14.94 | 2.43 | 9.44 | 2.26 | 1.00 | 1.00 | 6.63 | 6.18 | 0.6414 | 3.95 | 3.98 | 207,141.30 | 9.74 | 11.86 | 13.61 | 16.87 | 33.68 | 34.65 | 15.18 | 15.68 | 1.17 | -- | 0.0824 | 10.95 | 3.04 | 11.04 | -2.16 | 13.58 | 11.15 | -- |
| Carl Zeiss Meditec AG | 2.20bn | 120.62m | 2.40bn | 5.78k | 19.51 | -- | -- | 1.09 | 1.37 | 1.37 | 25.58 | -- | -- | -- | -- | 381,084.40 | -- | 8.00 | -- | 9.78 | 52.19 | 56.02 | 5.53 | 11.56 | -- | 7.38 | -- | 33.14 | 7.82 | 10.78 | -20.99 | 2.90 | 11.23 | 1.92 |
| Ottobock SE & Co KgaA | 1.64bn | 57.90m | 3.67bn | -- | 63.44 | 16.05 | 19.28 | 2.24 | 0.9048 | 0.9048 | 25.67 | 3.58 | -- | -- | -- | -- | -- | -- | -- | -- | 52.42 | -- | 3.42 | -- | 0.6458 | 3.18 | 0.8358 | -- | 7.33 | -- | -38.37 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to SCHOTT Pharma AG & Co KgaA's reporting currency: Euro EUR
12.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price International Ltd.as of 29 Oct 2025 | 7.55m | 5.01% |
| Capital Research & Management Co. (World Investors)as of 24 Sep 2025 | 4.37m | 2.90% |
| Union Investment Privatfonds GmbHas of 30 Sep 2025 | 2.46m | 1.63% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 1.33m | 0.88% |
| T. Rowe Price Hong Kong Ltd.as of 31 Dec 2025 | 1.14m | 0.76% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 655.66k | 0.44% |
| Grandeur Peak Global Advisors LLCas of 31 Oct 2025 | 611.18k | 0.41% |
| Montanaro Asset Management Ltd.as of 31 Dec 2025 | 510.00k | 0.34% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 404.30k | 0.27% |
| Lupus alpha Asset Management AGas of 30 Jun 2025 | 298.70k | 0.20% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
